Dual-Armed Oncolytic Myxoma Virus Encoding IFN-γ and CD47 Promotes Lymphocyte Infiltration and Tumor Suppression of Syngeneic Murine Melanoma

Dual-Armed Oncolytic Myxoma Virus Encoding IFN-γ and CD47 Promotes Lymphocyte Infiltration and Tumor Suppression of Syngeneic Murine Melanoma

Myxoma virus (MyxV) is a rabbit-specific poxvirus. However, its ability to selectively target tumor cells has established it as a safe and effective anticancer therapy. To strengthen its preclinical efficacy, transgenes that can prolong cancer cell infection and enhance anti-tumor effector functions...

Full description

Bibliographic Details
Main Authors:	Jong Kyu Woo, Tae-Geuk Kim, Na Yeon Im, Ka-Yeon Son, Minhyeon Cho, Yeo Jin Jeong, Jeong-Im Hong, BoRim Kang, Gansukh Enkhtaivan, Nam-Hyuk Cho, Tommy Alain, Dong Guk Park, Yeon-Sook Lee
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Series:	Cancers
Subjects:	oncolytic virus Armed-Myxoma virus CD47 IFN-γ tumor-infiltrating lymphocytes (TIL) Foxp3+ CD4+ regulatory T-cell (T-reg)
Online Access:	https://www.mdpi.com/2072-6694/15/19/4703

Similar Items

Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma
by: John D. Christie, et al.
Published: (2022-01-01)

Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
by: Joanna Jazowiecka-Rakus, et al.
Published: (2020-09-01)

Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma
by: Alpay Yeşilaltay, et al.
Published: (2024-01-01)

Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits
by: Laura V. Ashton, et al.
Published: (2020-05-01)

Oncolytic Myxoma virus Increases Autophagy in Multiple Myeloma
by: Alpay Yeşilaltay, et al.
Published: (2024-03-01)

Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
by: Bernice Nounamo, et al.
Published: (2017-09-01)

Oncolytic Viruses for Multiple Myeloma Therapy
by: Christine M. Calton, et al.
Published: (2018-06-01)

Prognostic significance of immunoscore related markers in bladder cancer
by: Ali Ariafar, et al.
Published: (2022-08-01)

T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms
by: Sara Fraticelli, et al.
Published: (2023-04-01)

Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma
by: Zhang Shu-Cheng, et al.
Published: (2012-09-01)

MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC
by: Dewi Masyithah Darlan, et al.
Published: (2021-01-01)

Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma
by: John D. Christie, et al.
Published: (2021-09-01)

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.
by: Tiphaine Delaunay, et al.
Published: (2018-03-01)

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
by: Joanna Jazowiecka-Rakus, et al.
Published: (2022-04-01)

CD8+ T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
by: Aldo Pourchet, et al.
Published: (2016-03-01)

Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1<sup>+</sup> Subsets in Mouse Immunocompetent Models
by: Alvaro Morales-Molina, et al.
Published: (2020-07-01)

Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma
by: Joanna Jazowiecka-Rakus, et al.
Published: (2021-03-01)

IN VITRO GENERATION AND CHARACTERIZATION OF HUMAN REGULATORY T-CELLS
by: E. V. Kurganova, et al.
Published: (2014-07-01)

Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways
by: Masmudur M. Rahman, et al.
Published: (2020-05-01)

A SIRPα‐Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer
by: Yao Huang, et al.
Published: (2020-03-01)

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
by: Ryosuke Ono, et al.
Published: (2021-03-01)

Oncolytic vaccinia virus induces a novel phenotype of CD8+ effector T cells characterized by high ICOS expression
by: Midori Yamashita, et al.
Published: (2021-03-01)

Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma
by: Lishu Chen, et al.
Published: (2022-03-01)

Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study
by: Annalisa Zeppellini, et al.
Published: (2021-03-01)

Green synthesis of oncolytic Newcastle disease virus-loaded thiolated chitosan nanoformulation for CD44 targeted delivery and sustained release of virus in cervical cancer xenografts
by: Kousain Kousar, et al.
Published: (2023-08-01)

Oncolytic virus immunotherapy: future prospects for oncology
by: Junaid Raja, et al.
Published: (2018-12-01)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01)

Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01)

Recent progress in combination therapy of oncolytic vaccinia virus
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)

Oncolytic Virus-Induced Autophagy in Glioblastoma
by: Margarita Kamynina, et al.
Published: (2021-07-01)

Past, Present and Future of Oncolytic Reovirus
by: Louise Müller, et al.
Published: (2020-10-01)

Células T regulatórias naturais (T REGS) em doenças reumáticas Natural regulatory T cells in rheumatic diseases
by: Wilson de Melo Cruvinel, et al.
Published: (2008-12-01)

Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
by: Mengyuan Li, et al.
Published: (2023-09-01)

Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01)

Myxoma Virus and the Leporipoxviruses: An Evolutionary Paradigm
by: Peter J. Kerr, et al.
Published: (2015-03-01)

The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density
by: Sören Schnellhardt, et al.
Published: (2022-01-01)

Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity
by: Su-Nam Jeong, et al.
Published: (2020-04-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)

The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer
by: Scott D. Haller, et al.
Published: (2020-11-01)